Density and binding characteristics of beta-adrenoceptors in the normal and failing equine myocardium.
Authors: Horn J, Bailey S, Berhane Y, Marr C M, Elliott J
Journal: Equine veterinary journal
Summary
# Editorial Summary: Beta-adrenoceptor Changes in Equine Heart Failure Understanding how the heart's response to stress hormones alters during disease is crucial for managing cardiac patients, yet equine myocardial adrenergic receptor characteristics have received little attention compared to human and canine research. Horn and colleagues used radioligand binding techniques on ventricular tissue from 19 normal horses and 10 with heart failure, measuring both the density and subtype distribution of beta-adrenoceptors using selective antagonists. Whilst overall receptor density remained unchanged between healthy and failing hearts (approximately 93–110 fmol/mg protein), a critical difference emerged: normal equine ventricles showed almost exclusively beta1-adrenoceptors, but some heart failure cases demonstrated a high-affinity population of beta2-adrenoceptors that was absent in health. This shift towards beta2-adrenoceptor expression in failing hearts potentially reflects a maladaptive response occurring in equine cardiac disease, with implications for understanding why traditional beta-blocking protocols may need tailoring in horses with heart failure. The findings warrant further investigation into whether beta2-selective agents might offer therapeutic advantages in specific equine cardiac conditions, and highlight important species differences from the well-characterised human and canine models that practitioners often rely upon.
Read the full abstract on PubMed
Practical Takeaways
- •Understanding beta-adrenoceptor changes in equine heart failure may inform future therapeutic approaches targeting specific adrenergic pathways in cardiac disease management
- •The apparent preservation of overall beta-adrenoceptor density in failing equine hearts differs from human and canine disease patterns, suggesting species-specific adaptations to cardiac stress
- •Individual variation in beta2-adrenoceptor expression during heart failure (seen in only 50% of cases) indicates heterogeneous disease pathophysiology that may require individualized treatment strategies
Key Findings
- •Normal equine ventricular myocardium possesses predominantly beta1-adrenoceptors (Ki 30.4±24.8 nmol/l) with CGP20712A 26 times more potent than ICI118.551
- •Beta-adrenoceptor density did not significantly differ between normal (Bmax 93.4±20.5 fmol/mg protein) and heart failure (Bmax 110.0±21.2 fmol/mg protein) tissues
- •Heart failure cases showed monophasic CGP20712A displacement curves (Ki 45.6±39.7 nmol/l) but biphasic ICI118.551 curves in 5/10 horses with 11-31% high-affinity beta2-adrenoceptors
- •Appearance of high-affinity ICI118.551-binding receptors in some heart failure cases suggests selective upregulation of beta2-adrenoceptors in equine ventricular myocardium during disease